The transplant program at NewYork-Presbyterian, Columbia, and Weill Cornell Medicine is among the longest established and most experienced program in the country. Due to their experience and expertise, our physicians can confidently care for some of the most complex transplants, including multi-organ transplants. Patients come to us from across the country and around the world for better outcomes and innovative procedures that allow for quicker access to transplants and also quicker recovery.
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
